Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Cases. Nov 16, 2014; 2(11): 654-660
Published online Nov 16, 2014. doi: 10.12998/wjcc.v2.i11.654
Published online Nov 16, 2014. doi: 10.12998/wjcc.v2.i11.654
Table 1 Risk factors associated with scrotal squamous cell carcinoma
Occupations |
Chimney sweepers, tar and paraffin workers, occupations with exposure to mineral and cutting oils, printing, metal working, car and aeroplane manufacture, car mechanics, commercial printing, aluminum worker, shale oil workers, pitch workers, engineering, steel production, cavalrymen |
Carcinogenic metals |
Arsenic, nickel, chromium |
Chronic mechanical irritation |
Chronic inflammatory states |
Chronic lymphedema, infective and surgical scars |
Lifestyle |
Poor personal hygiene, smoking |
Viruses |
HPV |
Ionizing Radiation |
Iatrogenic |
Coal tar, PUVA, radiotherapy, nitrogen mustard, Fowler’s solution |
Immunosuppression |
Acquired and inherited immunodeficiency, post transplant immunosuppression |
Table 2 Lowe’s staging of scrotal squamous cell carcinoma
A1 | Disease localized to scrotum |
A2 | Locally extensive disease involving adjacent structures (penis, perineum, testis or cord, and pubic bone) by continuity but without evident metastasis |
B | Superficial lymph node metastasis, resectable |
C | Pelvic lymph node metastasis or any unresectable metastasis |
D | Distant metastasis beyond regional nodes |
Table 3 TNM staging system for squamous cell carcinoma
Stage | Primary tumour | Regional lymph nodes | Distant metastasis |
Stage 0 | Tis = carcinoma in situ | N0 = no regional lymph node involvement | M0 |
Stage I | T1 = tumour 2 cm or less | N0 | M0 |
Stage II | T2 = tumour > 2 cm but < 5 cm | N0 | M0 |
T3 = tumour > 5 cm | N0 | M0 | |
Stage III | T4 = Invasion of deeper extradermal structures | N0 | M0 |
Any T | N1 = regional lymph node spread. | M0 | |
Stage IV | Any T | Any N | M1 = distant metastasis. |
Table 4 Case series with epidemiology, management and outcomes of scrotal squamous cell carcinoma published after 2000
Ref. | n | Design | Cohort characteristics | Summary |
Stern et al[17], 2002 | 17 | Prospective multi-institutional cohort study | 892 men first treated with PUVA | Dose-dependent increase in the risk of genital tumors in men treated with PUVA |
Seabra et al[19], 2007 | 6 | Retrospective single institution | Age: 52 (31-89) Race: Ca: 2; Bl: 2; Oth: 1; Unknown: 1 Staging: LC: 4, RL: 1, DD: 1 | 4/6 WLE; 1/6 WLE + SLNB; 1/6 was unresectable: 1 developed LN metastasis and was treated with chemo/radiation Patient with unresectable disease and was treated with chemotherapy and subsequently died |
Wright et al[2], 2008 | 151 | SEER (1973-2002) | Age: 682 Race: Ca 117 (77.5); Bl 24 (15.9); Oth 10 (6.6) | SCC had the worse survival compared to other histological subtypes |
Verhoeven et al[1], 2010 | 53 | NCR (1989-2006) | Age: 56.5 Staging: Stg 0: 1 (1.9), Stg 1: 22 (41.5), Stg 2: 18 (34), Stg 3: 2 (3.8), Stg 4: 0, Unk: 10 (18.9) | SCC had the worse survival compared to other histological subtypes: 1 yr relative survival 93% 3 yr relative survival 80% 5 yr relative survival 77% |
Johnson et al[16], 2013 | 269 | SEER (1973-2006) | Age: 65.42± 14.9 Race: Ca 206 (76.6%), Bl 43 (16.0%), As 12 (4.5%), Hi 18 (6.7%), Oth 8 (3.0%) Staging: LC 205 (76.2%), RL 54 (20.1%), DD 10 (3.7%) | The median OS for patients with SCC was 115 (95%CI: 97-133) mo |
Matoso et al[18], 2014 | 29 | Retrospective multi-institutional | Age: 55 (30-74) Race: Ca 19 (65.5%), Bl 10 (34.5%) Follow up: 37 mo | 25/29 WLE; 1/29 WLE + LND; 3/29 imiquimod post WLE: 13 (45%) with1 margins required re-excision1 3/29 local recurrence: 2 WLE; 1 WLE/RT 3 /29 with lymphadenopathy lost to follow-up |
- Citation: Vyas R, Zargar H, Trolio RD, Lorenzo GD, Autorino R. Squamous cell carcinoma of the scrotum: A look beyond the chimneystacks. World J Clin Cases 2014; 2(11): 654-660
- URL: https://www.wjgnet.com/2307-8960/full/v2/i11/654.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v2.i11.654